Literature DB >> 11742536

Monomers of the catalytic domain of human neuropathy target esterase are active in the presence of phospholipid.

Jane Atkins1, Lee H Luthjens, Marinus L Hom, Paul Glynn.   

Abstract

NEST is a hydrophobic recombinant polypeptide comprising the catalytic domain (residues 727-1216) of neuropathy target esterase. NEST in bacterial lysates has potent esterase activity, which is lost after its solubilization and purification in detergent-containing solutions. Activity in purified NEST preparations was restored by the addition of phospholipids before the removal of detergent by dialysis. The pattern of digestion by proteinase K of NEST-phospholipid complexes suggested that NEST might incorporate in a topologically random fashion into nascent liposomes and that the bulk of each NEST molecule might be exposed either to the liposome lumen or the external medium. Significant quantities of NEST were liberated from NEST-phospholipid complexes by treatment with dilute acid or alkali, suggesting that charge interactions might contribute to the association; however, NEST was irreversibly denatured at these pH values. Treatment of NEST-phospholipid complexes with glutaraldehyde afforded some protection against the inactivation of esterase activity by detergent but the pattern of cross-linked forms of NEST generated did not indicate pre-existing oligomers. Similarly, the inactivation of esterase activity in NEST-phospholipid complexes by radiation indicated that NEST monomers are catalytically active. The foregoing observations are not compatible with structural algorithms predicting that the catalytic serine residue lies at the centre of one of three transmembrane helices in NEST.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11742536      PMCID: PMC1222286          DOI: 10.1042/0264-6021:3610119

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

Review 1.  Bacterial phospholipase A: structure and function of an integral membrane phospholipase.

Authors:  H J Snijder; B W Dijkstra
Journal:  Biochim Biophys Acta       Date:  2000-10-31

2.  Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man.

Authors:  M J Lush; Y Li; D J Read; A C Willis; P Glynn
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

3.  The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters.

Authors:  M K Johnson
Journal:  J Neurochem       Date:  1974-10       Impact factor: 5.372

Review 4.  Neuropathy target esterase.

Authors:  P Glynn
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

Review 5.  News from the interface: the molecular structures of triacylglyceride lipases.

Authors:  Z S Derewenda; A M Sharp
Journal:  Trends Biochem Sci       Date:  1993-01       Impact factor: 13.807

6.  Membrane association of and critical residues in the catalytic domain of human neuropathy target esterase.

Authors:  J Atkins; P Glynn
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

Review 7.  Structure and mechanism of human cytosolic phospholipase A(2).

Authors:  A Dessen
Journal:  Biochim Biophys Acta       Date:  2000-10-31

8.  Modulation of neurotoxic esterase activity in vitro by phospholipids.

Authors:  C N Pope; S Padilla
Journal:  Toxicol Appl Pharmacol       Date:  1989-02       Impact factor: 4.219

9.  The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase.

Authors:  M K Johnson
Journal:  Biochem J       Date:  1969-10       Impact factor: 3.857

10.  Human hepatic lipase subunit structure determination.

Authors:  J S Hill; R C Davis; D Yang; J Wen; J S Philo; P H Poon; M L Phillips; E S Kempner; H Wong
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

View more
  4 in total

1.  PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum.

Authors:  Matthis Synofzik; Michael A Gonzalez; Charles Marques Lourenco; Marie Coutelier; Tobias B Haack; Adriana Rebelo; Didier Hannequin; Tim M Strom; Holger Prokisch; Christoph Kernstock; Alexandra Durr; Ludger Schöls; Marcos M Lima-Martínez; Amjad Farooq; Rebecca Schüle; Giovanni Stevanin; Wilson Marques; Stephan Züchner
Journal:  Brain       Date:  2013-12-19       Impact factor: 13.501

2.  Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.

Authors:  Galina F Makhaeva; Elena V Rudakova; Nichole D Hein; Olga G Serebryakova; Nadezhda V Kovaleva; Natalia P Boltneva; John K Fink; Rudy J Richardson
Journal:  J Appl Toxicol       Date:  2014-01-07       Impact factor: 3.446

3.  Neuropathy target esterase (NTE/PNPLA6) and organophosphorus compound-induced delayed neurotoxicity (OPIDN).

Authors:  Rudy J Richardson; John K Fink; Paul Glynn; Robert B Hufnagel; Galina F Makhaeva; Sanjeeva J Wijeyesakere
Journal:  Adv Neurotoxicol       Date:  2020-03-03

4.  Pure Cerebellar Ataxia with Homozygous Mutations in the PNPLA6 Gene.

Authors:  Sarah Wiethoff; Conceição Bettencourt; Reema Paudel; Prochi Madon; Yo-Tsen Liu; Joshua Hersheson; Noshir Wadia; Joy Desai; Henry Houlden
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.